Abstract | BACKGROUND: METHODS AND RESULTS: TNF-α (4 μg/kg) was injected into the tail vein of 20 male Swiss albino mice (TNF group) and saline into 20 control mice (CON group). The dose was carefully chosen to avoid any significant decrease in left ventricular (LV) function. Animals were killed after 16 weeks and their atria examined for fibrosis. We found increased atrial fibrosis in the TNF group compared with the CON group [372.8±21.5 arbitrary units (a.u.) vs. 56.9±6.5 a.u., respectively, mean±SEM; P<0.0001] and decreased connexin-40 immunofluorescence [7.5±0.4 a.u vs. 40.4±1.9 a.u, respectively; P<0.0001]. Transforming growth factor-β [TGF-β: 95.6±1.8 a.u vs. 29.4±5.8 a.u; P<0.001], α-smooth muscle actin (α-SMA: 97.9±13.0 a.u vs. 50.1±18.5 a.u; P<0.05] and matrix metalloproteinase 2 ( MMP-2)/GAPDH levels [157.3±26.4 a.u vs. 105.8±13.3 a.u; P<0.05] were also increased in the TNF group. CONCLUSIONS: TNF-α is involved in the pathogenesis of atrial fibrosis and altered connexin-40 expression in mice through the TGF-β signaling pathway, activation of myofibroblasts and increased secretion of MMPs. Collectively, these changes may contribute to the arrhythmogenic substrate and development of AF.
|
Authors | Reginald Liew, Katwadi Khairunnisa, Yacui Gu, Nicole Tee, New Oo Yin, Tin Maung Naylynn, Kyaw Thu Moe |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 77
Issue 5
Pg. 1171-9
( 2013)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 23370453
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Actins
- Connexin 43
- Connexins
- GJA1 protein, mouse
- Smad3 Protein
- Smad3 protein, mouse
- Transforming Growth Factor beta
- Tumor Necrosis Factor-alpha
- alpha-smooth muscle actin, mouse
- connexin 40
- Matrix Metalloproteinase 2
- Mmp2 protein, mouse
|
Topics |
- Actins
(metabolism)
- Animals
- Arrhythmias, Cardiac
(chemically induced, metabolism, pathology, physiopathology)
- Atrial Function
(drug effects)
- Connexin 43
(metabolism)
- Connexins
(metabolism)
- Down-Regulation
- Fibrosis
- Fluorescent Antibody Technique
- Heart Atria
(drug effects, metabolism, pathology, physiopathology)
- Injections, Intravenous
- Male
- Matrix Metalloproteinase 2
(metabolism)
- Mice
- Myofibroblasts
(drug effects, metabolism, pathology)
- Signal Transduction
(drug effects)
- Smad3 Protein
(metabolism)
- Time Factors
- Transforming Growth Factor beta
(metabolism)
- Tumor Necrosis Factor-alpha
(administration & dosage, toxicity)
|